Annual General Shareholders Meeting 2023: Sonova shareholders approve all motions of the Board of Directors

Media Release

Stäfa (Switzerland), June 12, 2023 At the 38th Annual General Meeting (AGM) of Sonova Holding AG, all of the proposals submitted by the Board of Directors were approved. More than 400 shareholders personally attended the AGM in Zurich. In total, 65% of the share capital was represented.

The shareholders approved the Annual Report, the Annual Consolidated Financial Statements of the Group and the Annual Financial Statements of Sonova Holding AG for the 2022/23 financial year and authorized the proposed appropriation of retained earnings and a gross dividend of CHF 4.60 per registered share. This amounts to a payout of approximately CHF 274.1 million, corresponding to an adjusted payout ratio of 41%. The distribution will be made with the anticipated value date of June 20, 2023.

The shareholders formally approved the discharge of the members of the Board of Directors and the Management Board for the 2022/23 financial year. With the exception of Jinlong Wang, all members of the Board of Directors stood for re-election and were confirmed individually for a further term of office. 
The Chair of the Board of Directors, Robert F. Spoerry, was confirmed in office for another term. Roland Diggelmann (chair), Lukas Braunschweiler and Stacy Enxing Seng were re-elected to the Nomination & Compensation Committee. In addition, Julie Tay was newly elected as member of the Nomination & Compensation Committee. 

The compensation report for the 2022/23 financial year was ratified by the shareholders in a non-binding advisory vote. In two separate binding votes, the shareholders approved the maximum aggregate amount of compensation of the Board of Directors covering the time period from the AGM 2023 to the AGM 2024 and the maximum aggregate amount of compensation of the Management Board for the 2024/25 financial year. Furthermore, the capital reduction through cancellation of shares was approved. All proposed amendments to the Articles of Association were accepted.

Ernst & Young AG, Zurich, was re-elected as Auditor for a period of one year and the Law Office Keller AG, Zurich, was re-elected as the Independent Proxy.

The next AGM will be convened on June 11, 2024.

The minutes of the AGM 2023 (in German), which also include the detailed voting results, will soon be available on the Sonova website under the following link: https://www.sonova.com/en/AGM.
 

End

Disclaimer
This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of managements views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonovas control. Should one or more of these risks or un-certainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.

About Sonova
Sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids and cochlear implants. The Group was founded in 1947 and is headquartered in Stäfa, Switzerland.

Sonova operates through four businesses Hearing Instruments, Audiological Care, Consumer Hearing and Cochlear Implants and the core brands Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics as well as recognized regional brands. The Groups globally diversified sales and distribution channels serve an ever growing consumer base in more than 100 countries.

In the 2022/23 financial year, the Group generated sales of CHF 3.7 billion, with a net profit of CHF 658 million. Over 17,000 employees are working on achieving Sonovas vision of a world where everyone enjoys the delight of hearing.

For more information please visit www.sonova.com.

Sonova shares (ticker symbol: SOON, Security no: 1254978, ISIN: CH0012549785) have been listed on the SIX Swiss Exchange since 1994. The securities of Sonova have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the U.S. Securities Act), or under the applicable securities laws of any state of the United States of America, and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements under the U.S. Securities Act and in compliance with applicable state securities laws, or outside the United States of America to non-U.S. Persons in reliance on Regulation S under the U.S. Securities Act.